+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drospirenone"

Endometriosis- Pipeline Insight, 2025 - Product Thumbnail Image

Endometriosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
Female Contraception - Pipeline Review, H1 2020 - Product Thumbnail Image

Female Contraception - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 92 Pages
  • Global
From
From
From
From
From
Hormonal Contraceptives Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Hormonal Contraceptives Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Contraceptive Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Contraceptive Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Drospirenone is a synthetic progestin used in women's health for contraception and hormone replacement therapy. It is a fourth-generation progestin, which is known to have fewer androgenic side effects than earlier generations. It is used in combination with estrogen in oral contraceptive pills, and is also used in hormone replacement therapy to treat menopausal symptoms. Drospirenone is also used to treat premenstrual dysphoric disorder, a condition characterized by severe mood swings and physical symptoms before menstruation. Drospirenone is available in many forms, including oral tablets, transdermal patches, and vaginal rings. It is also available in combination with other hormones, such as estradiol and ethinyl estradiol. Several pharmaceutical companies manufacture and market drospirenone-containing products, including Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more